Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Traits
Traits linked to NF2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
The Human Phenotype Ontology links 131 traits to NF2, by body system: features seen in people with one of the gene's rare conditions.
Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
Abnormality of the nervous system
Abnormality of the eye
| Trait | How often it is seen |
|---|---|
| Juvenile posterior subcapsular lenticular opacities | Very often (80–99%) |
| Abnormality of the eye | Often (30–79%) |
| Bitemporal hemianopia | Often (30–79%) |
| Clouding of the lens of the eye | Often (30–79%) |
| Cortical cataract | Often (30–79%) |
| Decreased clarity of vision | Often (30–79%) |
| Posterior subcapsular cataract | Often (30–79%) |
| Abnormal kinetic perimetry test | Sometimes (5–29%) |
| Blindness | Sometimes (5–29%) |
| Double vision | Sometimes (5–29%) |
| Epiretinal membrane | Sometimes (5–29%) |
| Eye muscle paralysis | Sometimes (5–29%) |
| Lazy eye | Sometimes (5–29%) |
| Oculomotor nerve palsy | Sometimes (5–29%) |
| Optic nerve issue | Sometimes (5–29%) |
| Papilledema | Sometimes (5–29%) |
| Slow decrease in sharpness of vision | Sometimes (5–29%) |
| Visual acuity test abnormality | Sometimes (5–29%) |
| Visual loss | Sometimes (5–29%) |
| Weak extraocular muscles | Sometimes (5–29%) |
| Bulging eye | Rarely (1–4%) |
| Remnants of the hyaloid vascular system | Rarely (1–4%) |
Abnormality of the endocrine system
| Trait | How often it is seen |
|---|---|
| Decreased circulating ACTH concentration | Often (30–79%) |
| Decreased circulating follicle stimulating hormone concentration | Often (30–79%) |
| Decreased circulating luteinizing hormone level | Often (30–79%) |
| Decreased serum estradiol | Often (30–79%) |
| Decreased serum testosterone level | Often (30–79%) |
| Hypogonadotropic hypogonadism | Often (30–79%) |
| Increased circulating prolactin concentration | Often (30–79%) |
| Low blood cortisol level | Often (30–79%) |
| Low thyroid gland function due to abnormal pituitary gland | Often (30–79%) |
| Secondary growth hormone deficiency | Often (30–79%) |
| Abnormal hypothalamus physiology | Sometimes (5–29%) |
| Enlarged pituitary gland | Sometimes (5–29%) |
| Hypothalamic hypothyroidism | Sometimes (5–29%) |
| Neoplasm of the anterior pituitary | Sometimes (5–29%) |
| Reduced circulating prolactin concentration | Sometimes (5–29%) |
| Neoplasm of the posterior pituitary | Rarely (1–4%) |
Abnormality of the ear
| Trait | How often it is seen |
|---|---|
| Bilateral vestibular schwannoma | Very often (80–99%) |
| Vestibular schwannoma | Very often (80–99%) |
| Hearing impairment | Often (30–79%) |
| Sensorineural hearing impairment | Often (30–79%) |
| Unilateral vestibular schwannoma | Often (30–79%) |
| Dizziness | Sometimes (5–29%) |
| Ringing in ears | Sometimes (5–29%) |
| Ear pain | Rarely (1–4%) |
Abnormality of head or neck
| Trait | How often it is seen |
|---|---|
| Abnormality of the sense of smell | Sometimes (5–29%) |
| Bell's palsy | Sometimes (5–29%) |
| Retinal hamartoma | Sometimes (5–29%) |
| Lisch nodules | Rarely (1–4%) |
| Neoplasm of the tongue | Rarely (1–4%) |
Abnormality of the integument
| Trait | How often it is seen |
|---|---|
| Birthmark | Often (30–79%) |
| Peripheral schwannoma | Often (30–79%) |
| Neurofibroma | Sometimes (5–29%) |
| Patchy darkened skin | Sometimes (5–29%) |
| Skin cancer | Sometimes (5–29%) |
Abnormality of the musculoskeletal system
| Trait | How often it is seen |
|---|---|
| Fatty lump | Sometimes (5–29%) |
| Functional motor deficit | Sometimes (5–29%) |
| Muscle weakness | Sometimes (5–29%) |
| Scoliosis | Sometimes (5–29%) |
| Back pain | Rarely (1–4%) |
Abnormality of limbs
| Trait | How often it is seen |
|---|---|
| Decreased arm strength | Sometimes (5–29%) |
| Foot drop | Sometimes (5–29%) |
| Lower limb muscle weakness | Sometimes (5–29%) |
| Wrist drop | Sometimes (5–29%) |
Abnormality of the genitourinary system
| Trait | How often it is seen |
|---|---|
| Abnormal absence of menstruation | Often (30–79%) |
| Difficulty getting a full erection | Often (30–79%) |
| Uterine leiomyoma | Sometimes (5–29%) |
| Loss of bladder control | Rarely (1–4%) |
Abnormal cellular phenotype
| Trait | How often it is seen |
|---|---|
| Chromosomal breakage induced by ionizing radiation | Very often (80–99%) |
| Increased sensitivity to ionizing radiation | Very often (80–99%) |
Abnormality of the cardiovascular system
| Trait | How often it is seen |
|---|---|
| Lumbosacral hemangioma | Sometimes (5–29%) |
| Fainting spell | Rarely (1–4%) |
Abnormality of the digestive system
| Trait | How often it is seen |
|---|---|
| Nausea and vomiting | Often (30–79%) |
| Poor swallowing | Sometimes (5–29%) |
Abnormality of the respiratory system
| Trait | How often it is seen |
|---|---|
| Abnormality on pulmonary function testing | Rarely (1–4%) |
| Progressive pulmonary function impairment | Rarely (1–4%) |
Abnormal tissue mass
| Trait | How often it is seen |
|---|---|
| Abnormal tissue mass | Sometimes (5–29%) |
Abnormality of blood and blood-forming tissues
| Trait | How often it is seen |
|---|---|
| Bleeding in brain | Rarely (1–4%) |
Abnormality of the thoracic cavity
| Trait | How often it is seen |
|---|---|
| Abnormal mediastinum morphology | Rarely (1–4%) |
Abnormality of the voice
| Trait | How often it is seen |
|---|---|
| Weak voice | Rarely (1–4%) |
Constitutional symptom
| Trait | How often it is seen |
|---|---|
| Pain | Often (30–79%) |
Growth abnormality
| Trait | How often it is seen |
|---|---|
| Obesity | Sometimes (5–29%) |
How often is among people with one of the gene's conditions, the most often across them, as the Human Phenotype Ontology records it. These pages describe traits and the research behind them; they are not a diagnosis, and a doctor or genetic counsellor is the person to ask about symptoms.
Where this comes from
- The Human Phenotype Ontology, release 2026-09-01: the traits linked to NF2 and how often each is seen. Find out more at hpo.jax.org.
Who We HelpOur ScienceProductsOutcomes
Log InAskSequence your genome↗
One test. A lifetime of answers.
From $449Free shipping · Results in 6–8 weeks